These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27072700)

  • 21. Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue.
    McDowell CL; Bryan Sutton R; Obermann WM
    Int J Biol Macromol; 2009 Oct; 45(3):310-4. PubMed ID: 19576239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of natural and synthetic inhibitors to human heat shock protein 90 and their clinical application.
    Petrikaitė V; Matulis D
    Medicina (Kaunas); 2011; 47(8):413-20. PubMed ID: 22123555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.
    Que NLS; Crowley VM; Duerfeldt AS; Zhao J; Kent CN; Blagg BSJ; Gewirth DT
    J Med Chem; 2018 Apr; 61(7):2793-2805. PubMed ID: 29528635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases.
    Ernst JT; Liu M; Zuccola H; Neubert T; Beaumont K; Turnbull A; Kallel A; Vought B; Stamos D
    Bioorg Med Chem Lett; 2014 Jan; 24(1):204-8. PubMed ID: 24332488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of 3,5-disubstituted-4-alkynylisoxozales as a novel class of HSP90 inhibitors.
    Sun J; Lin C; Qin X; Dong X; Tu Z; Tang F; Chen C; Zhang J
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3129-34. PubMed ID: 26112442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cloning of three heat shock protein genes (HSP70, HSP90α and HSP90β) and their expressions in response to thermal stress in loach (Misgurnus anguillicaudatus) fed with different levels of vitamin C.
    Yan J; Liang X; Zhang Y; Li Y; Cao X; Gao J
    Fish Shellfish Immunol; 2017 Jul; 66():103-111. PubMed ID: 28495509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving the Hsp90 Inhibitors Containing 4-(2,4-Dihydroxyphenyl)-1,2,3-thiadiazole Scaffold: Synthesis, Affinity and Effect on Cancer Cells.
    Kazlauskas E; Brukstus A; Petrikas H; Petrikaite V; Cikotiene I; Matulis D
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1593-1603. PubMed ID: 28270068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series.
    Taldone T; Patel PD; Patel M; Patel HJ; Evans CE; Rodina A; Ochiana S; Shah SK; Uddin M; Gewirth D; Chiosis G
    J Med Chem; 2013 Sep; 56(17):6803-18. PubMed ID: 23965125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hsp90n - An accidental product of a fortuitous chromosomal translocation rather than a regular Hsp90 family member of human proteome.
    Zurawska A; Urbanski J; Bieganowski P
    Biochim Biophys Acta; 2008 Nov; 1784(11):1844-6. PubMed ID: 18638579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors.
    Shao LD; Su J; Ye B; Liu JX; Zuo ZL; Li Y; Wang YY; Xia C; Zhao QS
    J Med Chem; 2017 Nov; 60(21):9053-9066. PubMed ID: 29019670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and computational biology of the molecular chaperone Hsp90: from understanding molecular mechanisms to computer-based inhibitor design.
    Verkhivker GM; Dixit A; Morra G; Colombo G
    Curr Top Med Chem; 2009; 9(15):1369-85. PubMed ID: 19860735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
    Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
    Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of N-(5-chloro-2,4-dihydroxybenzoyl)-(R)-1,2,3,4-tetrahydroisoquinoline-3-carboxamides as novel Hsp90 inhibitors.
    Liang C; Hao H; Wu X; Li Z; Zhu J; Lu C; Shen Y
    Eur J Med Chem; 2016 Oct; 121():272-282. PubMed ID: 27266997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opposite effect of Hsp90α and Hsp90β on eNOS ability to produce nitric oxide or superoxide anion in human embryonic kidney cells.
    Cortes-González C; Barrera-Chimal J; Ibarra-Sánchez M; Gilbert M; Gamba G; Zentella A; Flores ME; Bobadilla NA
    Cell Physiol Biochem; 2010; 26(4-5):657-68. PubMed ID: 21063103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Middle domain of human Hsp90 isoforms differentially binds Aha1 in human cells and alters Hsp90 activity in yeast.
    Synoradzki K; Bieganowski P
    Biochim Biophys Acta; 2015 Feb; 1853(2):445-52. PubMed ID: 25486457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heat shock protein 90: inhibitors in clinical trials.
    Biamonte MA; Van de Water R; Arndt JW; Scannevin RH; Perret D; Lee WC
    J Med Chem; 2010 Jan; 53(1):3-17. PubMed ID: 20055425
    [No Abstract]   [Full Text] [Related]  

  • 37. How Selective are Hsp90 Inhibitors for Cancer Cells over Normal Cells?
    Wang Y; Koay YC; McAlpine SR
    ChemMedChem; 2017 Mar; 12(5):353-357. PubMed ID: 28139075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones.
    Schulte TW; Akinaga S; Murakata T; Agatsuma T; Sugimoto S; Nakano H; Lee YS; Simen BB; Argon Y; Felts S; Toft DO; Neckers LM; Sharma SV
    Mol Endocrinol; 1999 Sep; 13(9):1435-48. PubMed ID: 10478836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying a C-terminal ATP binding sites-based novel Hsp90-Inhibitor in silico: a plausible therapeutic approach in Alzheimer's disease.
    Khalid S; Paul S
    Med Hypotheses; 2014 Jul; 83(1):39-46. PubMed ID: 24785461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yeast is selectively hypersensitised to heat shock protein 90 (Hsp90)-targetting drugs with heterologous expression of the human Hsp90beta, a property that can be exploited in screens for new Hsp90 chaperone inhibitors.
    Piper PW; Panaretou B; Millson SH; Truman A; Mollapour M; Pearl LH; Prodromou C
    Gene; 2003 Jan; 302(1-2):165-70. PubMed ID: 12527207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.